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Hybridization kineticsMicroRNA-122 positively modulates hepatitis C virus (HCV) through direct interactions with viral RNA. Three
microRNA-122 recognition elements (MREs) have been previously identiﬁed: two in the 5′UTR and one in the
3′UTR. Herein, we report the relative afﬁnity of microRNA-122 to these sites using viral RNA-coated magnetic
beads, with mutagenesis and probes to disrupt interactions of microRNA-122 at speciﬁc sites. We
demonstrate cooperativity in binding between the closely spaced MREs within the 5′UTR in vitro. We also
identiﬁed a well conserved fourth site in the coding region and showed that it is the highest afﬁnity MRE site.
Site-directedmutagenesis of the MREs in HCV subgenomic replicons expressed in Huh-7.5 cells demonstrated
competing roles of the stimulatory MREs in the 5′UTR with the inhibitory role of an MRE in the open reading
frame (ORF). These data have important implications in elucidating the mechanism of interaction between
microRNA-122 and HCV RNA.
Crown Copyright © 2010 Published by Elsevier Inc. All rights reserved.Introduction
Hepatitis C virus (HCV) is a positive sense RNA virus that currently
infects over 3% of the global population (Anon, 2002; Reed and Rice,
2000). The virus encodes three structural proteins (core, E1, and E2)
and seven non-structural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A,
and NS5B) (Chisari, 2005; Lindenbach and Rice, 2005). Clinical
outcomes of HCV chronic infection include cirrhosis and hepatocel-
lular carcinoma; additionally, it is one of the leading causes of liver
transplant. The current therapy for this growing global health concern
is a combination of pegylated interferon-α 2a and ribavirin. However,
this therapeutic strategy achieves sustained virological response in
only 50% of infected patients (McHutchison et al., 2006), so there
exists an urgent need for the design of novel therapies. This need is
emphasized by the lack of effective vaccine against the virus. HCV
relies on many host–virus interactions (Pezacki et al., 2010), and the
targeting of these interactions for drug development holds promise
because host targets are less likely to develop drug resistance in
patients. One such therapeutic approach currently under develop-
ment employs locked nucleic acid (LNA)-modiﬁed phosphorothioatear Sciences, National Research
A 0R6.
acki).
10 Published by Elsevier Inc. All rigoligonucleotides targeting microRNA-122 (miR-122), a small RNA
which positively modulates HCV (Henke et al., 2008; Jangra et al.,
2010; Jopling et al., 2008, 2005; Lanford et al., 2010; Lin et al., 2010).
MicroRNAs (miRNAs) are ~22 nucleotide endogenous small RNA
regulators of gene expression. They typically mediate their regulation
through induction of mRNA destabilization or translational repression
via binding to complementary sequences in the 3′ untranslated region
(3′UTR) of target mRNAs (Carthew and Sontheimer, 2009; Doench and
Sharp, 2004; Sontheimer and Carthew, 2005). Previous studies have
revealed that Watson-Crick base pairing complementarity between 7
and8 consecutive bases in the5′ endofmiRNAs (referred to as the ‘seed’
sequence) and a target mRNA sequence is sufﬁcient to deﬁne a
microRNA recognition site (or ‘seed’ site) (Fig. 1a) (Lewis et al., 2003).
With regards to HCV, miR-122 is a highly abundant, liver-speciﬁc
miRNA that positively modulates HCV replication, translation, and
virion production (Henke et al., 2008; Jangra et al., 2010; Jopling et al.,
2008, 2005; Lin et al., 2010). Within the UTRs of HCV RNA, three highly
conserved miR-122 recognition elements (MREs) exist with two in the
5′UTR and one in the 3′UTR (Henke et al., 2008; Jopling et al., 2008,
2005). The HCV 3′UTR MRE is located in the variable region (VR) stem
loop (MRE 3) while the two HCV 5′UTR MREs are closely spaced
between stem loops (SLs) I and II (MREs 1 and 2) (Fig. 1b). Although the
3′UTR site appears to have no role in the stimulation of viral replication
or translation (Henke et al., 2008), the relative contribution of the two5′
UTR binding sites for miR-122 to these processes is still a subject ofhts reserved.
Fig. 1. Secondary structure and miR-122 binding sites of interest in the 5′ and the 3′ ends of the HCV genome. (a) Binding of miR-122 guide strand as part of RNA induced silencing
complex (miRISC) to MREs with seed sequence (nucleotides 2–8 at the 5′ end) highlighted. (b) The secondary structure is shown for the 5′UTR and domains V and VI in the core
coding sequence along with the 3′UTR and a portion of the NS5B coding sequence. Numbers refer to the nucleotide positions of the full-length HCV genotype 1b isolate Con1.
Highlighted are the four microRNA response elements (MREs) of interest and the respective mutations used in this study. For all four sites, a double mutation was performed at seed
positions 3 and 4 (p3–4) while for only MRE 4, an additional non-coding (nc) double mutation was performed at seed positions 4 and 7 (p4,7).
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replication is more dependent on miR-122 binding to the 5′ site in
proximity to SL I (MRE1)while translation is equally stimulatedbymiR-
122 binding to both MREs 1 and 2 (Jangra et al., 2010). Studies to-date
have been limited to analysis of the outcome of exogenous addition or
sequestration of miR-122 and ofmutation analyses of these three MREs
(Henke et al., 2008; Jangra et al., 2010; Jopling et al., 2008, 2005).
The hybridization kinetics of miR-122 with these HCV MREs has yet
to be examined indepth. The impactof targetmRNA secondary structure
on microRNA potency has been well established (Kedde et al., 2007;
Kertesz et al., 2007; Long et al., 2007; Obernosterer et al., 2008; Robins
et al., 2005). Generally, areas of higher structure lead to decrease mRNA
sensitivity tomiRNA regulation due to limited accessibility (Kedde et al.,
2007; Kertesz et al., 2007; Long et al., 2007; Obernosterer et al., 2008;
Robins et al., 2005). In comparison tomRNAs, RNA-based viral genomes,
such as HCV, tend to be longer and adopt a greater degree of secondary
and higher-ordered RNA structures, which will have further impact on
miRNA seed site accessibility (Davis et al., 2008; Saganet al., 2010). Davis
et al. utilized highly advanced RNA structure prediction algorithms to
show that evolutionarily conserved, genome-scale ordered RNA struc-
tures (GORS) are quite prevalent in HCV (Davis et al., 2008); further-
more, several other studies have identiﬁed well-deﬁned cis-acting RNA
elements that modulate the viral life cycle (Diviney et al., 2008; Easton
et al., 2009; Friebe et al., 2005; Le et al., 1995; Shetty et al., 2010; Wang
and Siddiqui, 1995; Wang et al., 1995; You and Rice, 2008; You et al.,
2004). In fact, Simmonds and colleague suggested that GORS itself may
play a role in shielding RNA viruses from Dicer-mediated small RNA
regulation (Simmonds et al., 2004). Consequently, seed site accessibility
represents an important factor in determining the sites with which theendogenous pool of miR-122 predominantly interacts, especially under
limiting miR-122 conditions.
We previously reported a novel method of utilizing HCV viral RNA
coated magnetic beads (VRBs) to measure siRNA target site
accessibility (Sagan et al., 2010). We have extended the use of these
VRBs to analyze the relative afﬁnity of the three miR-122 MREs in the
HCV genome using DNA probes or mutations of seed sites to block
miR-122's binding at the MREs. Similarly, we characterize a fourth
MRE (MRE 4) in the HCV open reading frame (ORF), which is well
conserved except in genotypes 2 and 5. Additionally, a comparison of
the relative importance of the MREs is made using bicistronic RNA
constructs encoding the HCV IRES-driven luciferase reporter and
mutant seed sites in the HCV subgenomic replicon. The resulting
modulations of translation and replication levels due to the MRE
mutations provide insight into the competing stimulatory and
inhibitory roles of the MREs.
Results
VRB-based comparison of miR-122 target sites' hybridization
We have previously shown that the HCV replicon RNA (Fig. 2a),
under native conditions in aqueous solution, retains a complex, highly
ordered RNA structure representative of its in vivo conformation
(Sagan et al., 2010). This property was exploited in order to develop
an assay utilizing the HCV viral RNA coated magnetic beads (VRBs) to
distinguish the target site accessibility of siRNAs targets in various
regions of the genome. Herein, we have applied the VRB assay for the
measurement of hybridization kinetics of the miR-122 seed site
Fig. 2.miR-122 afﬁnity for HCV RNA seed sites. (a) Schematic diagram of HCV subgenomic replicon RNA. (b) Biotin-labeled replicons weremutated or blockedwith probes to prevent
miR-122 binding, incubated under native or denaturing conditions with Cy3-conjugated miR-122. The hybridized miRNAs-HCV RNA complex is then captured on magnetic
streptavidin-conjugated microbeads. The beads were washed and imaged by ﬂuorescence microscopy. (c,d) Hybridization of increasing concentrations of miR-122 (10nM–500nM)
to the VRBs in the presence or absence of probes (c) blocking miR-122 binding sites of interest (MREs 1–4). (d) The experiment was repeated using a decreased miR-122
concentration gradient (5 nm–100 nm) with mutations instead of probes to disrupt binding. All MREs were mutated at positions 3 and 4 of the seed site as shown in Fig. 1b. Slopes
from native hybridization of control siRNAs, NS5B 7256 (positive control directed against highly accessible portion of HCV) and GL3 (negative control with no target site in HCV
replicon) are also shown. The data represent the mean of three images from three independent hybridizations. For each image, net IODs were calculated from individual beads
(n=100) over the concentration gradients and were used to produce slopes. Error bars represent s.d. of three independent hybridizations. Student's t-test values for pairwise
comparisons of samples with three MREs blocked or mutated are shown in Table S4.
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ing the degree of complementarity) and accessibility of the folded
state of the HCV RNA target. Speciﬁcally, we sought to determine the
relative target site afﬁnity of miR-122 to the three well known MREs
of miR-122 in the HCV genome, MREs 1–3 (Fig. 1b). All VRB-based
target site afﬁnity analyses were performed on the HCV genotype 1b
subgenomic replicon containing stem loops (SLs) V and VI of the core
coding sequence (CCS) since these domains have been implicated in
interactions with the IRES (SLs II–IV) (Kim et al., 2003). The inclusion
of these domains allows for a more representative model of the higher
order RNA interactions that occur in the HCV genome.
As in our previous target site accessibility study, the HCV replicon
RNA was 3′ end labeled with maleimide-PEG11-biotin (Sagan et al.,
2010). In order to distinguish the relative afﬁnity of the MREs, DNA
probes were designed covering each of the MREs independently (Table
S1). Hybridization of the probes to the replicon was performed to block
miR-122 from binding to speciﬁc individual MREs; then the repliconRNA was hybridized to ﬂuorophore-conjugated miR-122 guide strand
under native conditions. Subsequently, the miRNA-hybridized HCV
replicon RNA was captured on streptavidin-coated magnetic microbe-
ads and visualized using ﬂuorescence microscopy to assess seed site
afﬁnity (Fig. 2b). To account for non-speciﬁc interactions of themiRNAs
to the beads, control reactions were performed in the absence of HCV
replicon RNA. Background levels of ﬂuorescence produced by these
images were used for normalization of net integrated optical density
(IOD) values, and, in general, weren't of statistical signiﬁcance
compared to the signal in the presence of viral RNA. The observed
ﬂuorescence in the presence of miR-122 and HCV RNA is representative
of the hybridization kinetics of the unblocked sites, which depends on
the target site accessibility, complementarities and thermodynamics
(i.e. GC content) for the different seed sites. Multiple combinations of
the probes were used in order to assess the afﬁnity of miR-122 towards
each independent MRE. Representative images of the miR-122
hybridizations on the VRBs are shown in Figs. S1a–c. Quantiﬁcation of
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increasing concentrations of miR-122 (10 nM to 500 nM) was used to
generate line graphs for miR-122 binding under each set of conditions
(Fig. S2). Similar to our previous study (Sagan et al., 2010), the slopewas
used as a measure of target site hybridization kinetics or, in this case,
miR-122's afﬁnity to seed sites. As a positive control, a highly potent
siRNA guide strand, NS5B-7256, directed against the NS5B region was
used in the absence of probes (Wilson et al., 2003).We have previously
shown this siRNA targets a highly accessible portion of theHCV replicon
RNA (Sagan et al., 2010) and, predictably, generates a considerably high
amount of signal in the VRB assay (Fig. 2c). Moreover, the signal
generatedby theNS5B-7256 siRNAwas considerably higher than that of
any of the miR-122 hybridizations; however, this was expected since
the siRNAs exhibit perfect complementaritywith their target sites in the
replicon as compared to the restricted complementarity of miR-122 to
its seed sequence region. As a negative control, the GL3 siRNA guide
strand was used in the absence of probes as it possesses no sequence
complementary to HCV replicon RNA and produces virtually no
difference in signal (Fig. 2c) when compared to the background, as
previously shown (Sagan et al., 2010). Together, these controls
demonstrate the speciﬁcity and sensitivity of the VRB-based technique.
High afﬁnity fourth miR-122 binding site in HCV RNA
In the presence of probes blocking MREs 1, 2 and 3 (Fig. 2c), results
from VRB assays showed that there was still a signiﬁcantly high signal
level compared to the background. This observation suggested that
theremight be additionalmiR-122binding sites in the replicon. Thuswe
consulted ViTa, an online database for predictedmiRNA binding sites in
viral genomes to look for additional sites (Hsu et al., 2007). The
additional predicted sites represented a combination of potential miR-
122 binding sites based on either seed site interactions ormarginal sites
with partial or no complementarity to the seed sequence with
compensatory binding to the 3′ end of the miR-122 (Table S2).
The in vitro VRB assay allows for a preliminary analysis of relative
microRNA afﬁnity for binding sites; however, it isn't entirely
representative of RISC-boundmiRNAs and other factors that inﬂuence
accessibility in vivo. For example, other RNA binding proteins are
known to modulate RNA accessibility for small RNAs (Jacobsen et al.,
2010; Kedde et al., 2007; Kertesz et al., 2007; Long et al., 2007;
Obernosterer et al., 2008).
Since seed sites represent the dominant miRNA binding site
characteristic (Bartel, 2009), our primary interest was identifying all
potential sites displaying maximum complementarity to the miRNA
seed sequence. Interestingly, the HCV replicon RNA sequence
displayed an additional potential 8 nucleotide seed site for miR-122
(MRE 4) found in the coding region of NS5B, the HCV-encoded RNA
dependent polymerase (Fig. 1b); miR-122 interactions with this site
could potentially explain the remaining signal observed. We focused
on this seed site as it displayed the highest complementarity (with
potential for supplementary binding with HCV at the 3′ end of the
miR-122) and the highest score (Betel et al., 2008) based on
complementarity and free energy of formation (Table S2). While
seed pairing is an important predictor of true microRNA binding sites
(Brennecke et al., 2005; Lewis et al., 2005, 2003), seed sites are neither
necessary nor sufﬁcient for miRNA-mediated regulation as seed sites
have been shown to be inactive when tested in reporter constructs
(Didiano and Hobert, 2006; Miranda et al., 2006). Thus, the extension
of the VRB assay to include the fourth site serves an additional
purpose in validating miR-122's interaction in vitro with MRE 4.
A fourth probe was designed to cover the newly discovered seed
site (Table 1) and, as expected, in the presence of all four probes
against MREs 1–4, the signal was reduced signiﬁcantly (Fig. S2).
However, blocking of this fourth site in addition to the three other
MREs still resulted in a signal level above background. This remaining
signal is likely attributed to non-speciﬁc miR-122 binding to the HCVRNA as well as binding to the aforementioned marginal sites.
Fluorescence analysis of miR-122 hybridization to the VRBs was
extended to include the fourth site (Fig. 2c). By analyzing the slopes of
hybridization produced by using three probes simultaneously
(thereby leaving one MRE available to miR-122 for binding), it is
possible to compare the hybridization kinetics of each individual site.
The probe based VRB assay suggests that the hierarchy of miR-122
afﬁnity to the seed sites is as follows: MRE 4N1N3N2 (Fig. 2c).
Site-directed mutagenesis of miR-122 seed sites in HCV replicons
The use of probes may induce changes in secondary structure of the
virus, so we repeated our analysis using double substitution mutations
in the MREs corresponding to the nucleotides 3 and 4 in the seed
sequence of miR-122 (p3–4) (Figs. 1a, b) to disrupt miR-122's
interactions with each individual MRE, as previously done (Jopling et
al., 2008, 2005). Furthermore, to better represent limiting kinetic
conditions, we decreased the miR-122 concentration range for the
analysis of the triple mutants to 5nM–100nM. The results of the
mutation-based VRB target site afﬁnity analysis under these conditions
(Fig. 2d) mirrored that of the initial probe-based study. Also, the probe-
based analysis was repeated using the decreased concentration range,
and the observed hierarchy followed the same trend (Fig. S3).
Cooperativity of miR-122 binding in vitro in HCV 5′UTR
By far, MRE 2 displayed the lowest afﬁnity according to the VRB
assay results (pb0.004) (Figs. 2c, d, and Table S4). It is interesting to
note that while MREs 1, 3, and 4 are predicted by the ViTa, the MRE 2
is not predicted by this database (Table S2). This is due in part to the
reduced level of complementarity of MRE 2 to the miR-122 seed
sequence compared to the other three MREs of interest (6 nts
compared to 8 nts) (Fig. 1b). This partially accounts for the observed
lowest afﬁnity towards miR-122 that MRE 2 exhibits among the four
MRES of interest. However, Jopling et al. found that binding to both
sites MRE 1 and 2 were required to ensure viral RNA ampliﬁcation,
(Jopling et al., 2008). Also, a recent study showed that miR-122
binding to both 5′ sites independently has a relatively equal positive
stimulation on HCV translation — suggesting that equal binding
occurs to both sites independently (Jangra et al., 2010). These studies
indicate that MRE 2 displays high efﬁcacy and retains some seed site
accessibility in vivo. In vitro, however, this may potentially be
attributed to the fact that MRE 2 is a more efﬁcient miR-122 binding
site due to its cooperativity with MRE 1 (Jopling et al., 2008). Previous
studies have suggested that closely spaced miRNA binding sites act
synergistically (Grimson et al., 2007; Saetrom et al., 2007); a potential
explanation is that binding at MRE 1 may decrease secondary
structure in the adjacent area, thereby increasing accessibility to
MRE 2. A closer examination of the probe-based VRB assay results
sheds some light on this cooperativity. The signal produced by the
HCV RNA with only both 5′UTR MREs unblocked (probes 3+4 in
Fig. 2b) is (1.8±0.2)×102 while the sum of the signals produced
when each individual site is accessible (probes 1+3+4 and 2+3+4
in Fig. 2b) is (1.2±0.2)×102. The increase (pb0.03) over the sum
implies that there is cooperativity exhibited between the two sites
(i.e. binding to one of the two sites increases binding to the other).
Inhibitory role of MRE 4 in HCV
The VRB assay results also highlight the binding efﬁcacy of miR-
122 to MRE 4 in vitro (Figs. 2c, d, and Fig. S3). However, the functional
role of MRE 4 during HCV replication is not known. Most ORF sites, in
fact, have been shown to be generally less effective (Grimson et al.,
2007). In order to assess the biological relevance of MRE 4 and
compare it to that of the three other sites, the HCV subgenomic
replicon containing p3–4 mutated MREs was introduced into Huh-7.5
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rates of translation and replication of the replicon were assessed. A
replicon lacking the stem loops in the core coding sequence was used
for this portion of the study as we found (data not shown), along with
others (Kim et al., 2003), that they decrease HCV IRES-dependent
translation.
Analysis of HCV RNA levels 72 h post-transfection by Northern blot
(Fig. 3a) revealed that mutations of MREs 1 and 2 resulted in
decreased viral titres as previously reported (Henke et al., 2008;
Jangra et al., 2010; Jopling et al., 2008, 2005; Lanford et al., 2010);
meanwhile, disruption of MRE 3 resulted in no signiﬁcant changes in
viral titres, also in accordance with previous studies (Henke et al.,
2008; Jopling et al., 2005). Conversely, mutations of the MRE 4
resulted in an overall increase in HCV RNA levels. These results were
similarly reproduced with quantitative RT-PCR at 72 and 120 h post-
transfection (Fig. S4). Furthermore, HCV IRES-driven expression of the
luciferase reporter was enhanced by mutations to MRE 4 (Fig. 3b).
These results were reproduced by electroporation of the same
constructs into Huh 7.5 cells (data not shown).
With regards to the newly discoveredMRE 4, no functional role for
this seed site has yet been established. In an effort to illuminate its
role, we had performed the same p3–4 mutations in MRE 4; however,
in the instance of MRE 4, this resulted in a substitutionmutation in the
NS5B gene. Therefore, we also performed an alternate p4,7 double
silent mutation (4nc) (Fig. 1b) in order to ensure the results we were
observing were not as a result of changes in the RNA polymerase
activity of NS5B, but strictly due to disruption of miR-122 binding at
this site. An increase in both viral RNA titres (Figs. 3a and S4) along
with a stimulation of HCV-IRES driven translation of the luciferase
reporter was seen (Fig. 3b) upon mutation of MRE 4. While it is wellFig. 3.Mutational analysis of miR-122 seed sites' roles in HCV translation and replication. Bici
miR-122 seed sites was transfected in Huh-7.5 cells. All MREs were mutated at positions 3 a
would occur as shown in Fig. 1b. (a) Northern blot analysis of HCV replicon expression in to
andmock transfections are also shown. Expression of β-actin was used as a loading control. R
also included to discern background levels. (b) Fireﬂy luciferase activity relative to wildtyp
harboring cells. *Pb0.05 relative to Luc 5.1 expressing cells. **Pb0.008 relative to Luc 5.1 expr
(Luc 5.1) after 24 (n=3) hours post transfection and cells also transfected with mutant miR-
122). Values in (b) and (c) were normalized by protein content, and error bars represent sestablished that miRNA binding sites in the 3′UTR have been known
to efﬁciently impede translation and induce mRNA destabilization,
seed sites in the ORF have generally been found to be less effective
(Grimson et al., 2007). However, our mutational analysis and VRB
assay results suggest that the ORF site (MRE 4) displays the highest
afﬁnity for miR-122 in vitro (pb0.0003) (Fig. 2d, Fig. S3, and Table S4)
and is quite functional in an inhibitory role in translation and
replication of the virus. Lastly, we have found that transfection of miR-
122 bearing compensatory mutations to restore the miRNA interac-
tion at MRE 4 resulted in decreased (pb0.001) HCV-IRES driven
translation of luciferase reporter thereby further validating MRE 4 as
an inhibitory miR-122 binding sites in HCV (Fig. 3c).
Discussion
Collectively, our study demonstrates the importance of the newly
characterized fourth miR-122 binding site in HCV RNA in its viral
lifecycle. Our target site afﬁnity analysis reveals that MRE 4 displays
the highest in vitro hybridization rate to miR-122 in HCV RNA
compared to the previously characterized sites. While prior studies
have proposed that miRNA targets sites in the coding region are less
frequent and effective (Bartel, 2009; Grimson et al., 2007), genome-
wide analyses have identiﬁed a signiﬁcant amount of ORF targeting
(Bartel, 2009). Gu and colleagues demonstrated that active translation
impedes miRISC association with mRNAs in the ORF by extending
coding regions to overlap 3′UTR miRNA target sites (Gu et al., 2009).
However, we report that MRE 4, found in the NS5B gene, has a potent
inhibitory role on HCV. This curious result may be explained by the
decreased local structure in NS5B leading to increased miR-122
accessibility, which compensates for the ability of ribosomes to clearstronic HCV subgenomic replicon with HCV IRES-driven luciferase reporter andmutated
nd 4 of the seed site; also, MRE 4 was mutated such that a non-coding mutation (4nc)
tal RNA extracted from Huh-7.5 cells 72 h post-transfection. Naïve HCV replicons (WT)
epresentative blot is shown (n=3). A replicon containing a deletion in the NS5B gene is
e (Luc 5.1) after 24 (n=3) and 72 (n=2) hours post transfection for MRE 4 mutant
essing cells. (c) Fireﬂy luciferase activity of cells expressingmutants relative to wildtype
122 (n=3) bearing compensatory mutations to the mutated MREs (mutated p3–4 miR-
.d. of independent experiments.
341N. Nasheri et al. / Virology 410 (2011) 336–344the miRISC association with MRE 4. Additionally, it has been
previously suggested that structural elements within HCV RNA
cause pausing of active translation by the ribosome (Xu et al.,
2001). Then it is possible that the surrounding local secondary
structure (Fig. 1b) impedes the ribosome, thereby stabilizing the
miRISC association with MRE 4, leading to reduced translation and
replication. It should be noted that the in vitro VRB assay does not take
into account the other factors that inﬂuence accessibility in vivo. These
factors include the inﬂuence of RISC or other RNA binding proteins,
which play a signiﬁcant role in modulating RNA accessibility for small
RNAs (Jacobsen et al., 2010; Kedde et al., 2007; Kertesz et al., 2007;
Long et al., 2007; Obernosterer et al., 2008). It is possible that such
additional host factors may be responsible for the increased efﬁcacy of
an ORF site like MRE 4. Alternatively, the increased complementarity
displayed by MRE 4 to miR-122, through its supplementary binding
at the 3′ end in addition to its seed sequence complementarity
(Table S1), may enable the miRNA to effectively withstand and block
active translation.
Conservational analysis of the MRE 4 in the HCV RNA ORF
demonstrates that the site is well-conserved in genotypes 1, 3, 4,
and 6, yet poorly conserved among genotypes 2 and 5 (Table S3).
Interestingly, this site is conserved in 91.3% of HCV genotype 1b
isolates, which represent a subtype of HCV that is known to be more
aggressive and more likely to proceed from acute to chronic infection
(Zein, 2000). We hypothesize that one potential evolutionary role for
miRNA sites in the ORF (MRE 4) is to suppress viral titres as ameans of
immune evasion, as previously suggested by Mahajan and others
(Mahajan et al., 2009). While the miR-122 mediated positive
modulation through interactions in the 5′UTR has been deemed
essential, the MRE 4 site negatively counterbalances the effects if MRE
1 and 2. The existence of both stimulatory and inhibitory miR-122
recognition elements within HCV RNA may help to maintain optimal
levels of HCV during infection.
While the existences of MREs 1, 2, and 3 were previously
established (Henke et al., 2008; Jopling et al., 2008, 2005), the role
of other ORF sites (e.g. MRE 4) has yet to be explained in the context of
HCV lifecycle. While the recent promise of antisense oligonucleotides
targeting miR-122 suggests that these potentially repressive sites
have a limited signiﬁcance on HCV compared to the positive
modulatory sites in the 5′UTR (MREs 1 and 2), our results herein
suggest that recruitment of miR-122 to the ORF site (MRE 4) results in
a decrease HCV levels likely resulting from negative effects on
translation, stability, or replication of HCV RNA. Further studies are
required to distinguish at which regulatory level (translational
repression or mRNA destabilization) MRE 4 plays a role. Since a
slightly lower increase on luciferase activity (i.e. decreased regulation
by MRE 4) at 72 h is seen compared to 24 h, we are inclined to believe
the effect is mainly on translational repression since the luciferase
activity at 24 h will be more representative of translation. However,
we cannot exclude the potential role of mRNA destabilization, which a
recent study suggests, is a predominant mechanism by which
mammalian miRNAs mediate their repression (Guo et al., 2010). For
future studies, it will also be of interest to monitor the relative
biological relevance of these type of MREs in other infectious HCV
models and compare the relative contributions of each site on
replication, translation, and virion production, as previously done
for MREs 1 and 2 (Henke et al., 2008; Jangra et al., 2010; Jopling et al.,
2008, 2005).
Jopling et al. previously demonstrated cooperativity of MRE 1 and
MRE 2 in mediating miR-122's positive modulation of HCV through
mutational analysis of a luciferase reporter with a HCV 5′UTR. Our VRB-
based target site analysis also demonstrates cooperativity in binding
betweenboth sites in the 5′UTR. A previous in vitro study, inwhichmiR-
122 binding at MRE 1 induced an opening in the conformation of the
IRES by disrupting a long-range annealing motif, supports this
hypothesis (Diaz-Toledano et al., 2009). It seems likely that miR-122'sbinding toMRE 1 is crucial to enable miR-122's access to MRE 2, at least
in vitro.
Overall, these results highlight the competing roles in HCV
replication and translation of the miR-122 binding sites in the 5′UTR
(stimulatory) compared to those in the ORF (inhibitory) (Fig. 4). This
study highlights the capacity of VRB assay to validate computationally
predicted miRNA target sites and evaluate the cooperativity of miRNA
binding to closely spaced target sites. Our target site accessibility
assay revealed the increased accessibility of MRE 1 compared to MRE
2 and the cooperativity in binding displayed between these two sites
in the 5′UTR. While miRNA binding sites in the ORF are generally
weaker, the results herein are the ﬁrst characterization of a fourth
miR-122 recognition element in the NS5B gene of HCV RNA. This site
plays a signiﬁcant inhibitory role at both the translational and
replication levels. The newly characterized miR-122 seed site appears
to be highly accessible, and its inhibition of HCVmay contribute to the
HCV's immune evasion and progression to chronic infection.
Materials and methods
HCV replicons, oligonucleotides, and mutagenesis
The pFK-I389luc/NS3-3′/5.1 plasmid containing the HCV subge-
nomic replicon (genotype 1b isolate Con1, Genbank Accession #
AJ242654) and the NS5B active site mutant replicon were kind gifts
from Dr. Ralf Bartenschlager (Institute of Hygiene, University of
Heidelberg, Heidelberg, Germany) (Lohmann et al., 1999). Insertion of
SL V andVI of the coreORF into the pFK-I389luc/NS3-3′/5.1 repliconwas
done using SL-NruI/AscI oligonucleotide (Table S1) (Sigma-Aldrich,
Oakville, ON). The fragment was restricted with NruI and AscI and
inserted into pFK-I389luc/NS3-3′/5.1 replicon. Mutagenesis of the pFK-
I389luc/NS3-3′/5.1 replicon was performed using QuikChange Lighting
kit (Stratagene, La Jolla, CA), and primers are listed in Table S1 according
to the manufacturer's protocol. RNA oligonucleotides were synthesized
by Dharmacon, Inc (Lafayette, CO). The sequences were 3′ Cy3-labeled
miR-122, 5′-UGUUGUGUGACAAUGGUGUUUGU-Cy3, miR-122*, 5′-
AAACGCCAUUAUCACACUAAAUA; and miR-122p3-4, 5′-UGCUGUGU-
GACAAUGGUGUUUGU. Duplexes were formed between the p3–4 form
of miR-122 and its complement (miR-122*) prior to transfection.
Cell culture, transfections, and electroporation
Adherent Huh-7.5 cells were cultured in Dulbecco'sModiﬁed Eagle
Medium (DMEM; Invitrogen, Burlington, ON) supplementedwith 100
nM nonessential amino acids (NEAA), 50 U/mL penicillin, 50 mg/mL
streptomycin, and 10% fetal bovine serum (FBS; PAA Laboratories,
Etobicoke, ON). Transfections were done using DMRIE-C (Invitrogen)
for the replicon and Lipofectamine 2000 for the oligonucleotides, both
following the manufacturer's protocol. Cells were harvested at the
speciﬁed time points for RNA and protein isolation. Huh-7.5 cells were
transfected with HCV subgenomic replicon RNA using a BTX ECM830
(Harvard Appartus Inc., Holliston, MA). Brieﬂy cells were washed
twice and resuspended with PBS. Ten micrograms of RNA was mixed
with 80 μL of washed cells with a density of 1.0×107cells/mL in a 1-
mm gap cuvette and was pulsed ﬁve times at 820 V, 99 μs pulse length
at 1.1-s intervals. After a 10-min recovery time, cells were resus-
pended in prewarmed DMEM and plated.
In vitro transcription (IVT)
In vitro transcripts were synthesized using the MEGAscript T7 kit
(Ambion, Austin, TX) according to the manufacturer's protocol.
Brieﬂy, the template DNA was linearized with the restriction enzyme
ScaI (New England Biolabs, Pickering, ON), ethanol precipitated for
30 min, and resuspended in RNase-free water to a ﬁnal concentration
of 0.5 μg/μL. The IVT reaction was set up in a ﬁnal volume of 20 μL and
Fig. 4. Competing roles of miR-122 seed sites in HCV RNA. Schematic depicting competing roles of microRNA binding sites in the 5′UTR (MREs 1 and 2) and those in the ORF and 3′
UTR (MREs 2 and 3) in the HCV RNA genome. MicroRNA-122, upon association to the RNA induced silencing complex (RISC), will use its guide strand to bind these competing sites.
This miRISC complex's association with the 5′UTR sites (b) will lead to an overall stimulatory effect on translation and replication. Conversely, binding with the ORF site (a) results in
repression of these processes.
342 N. Nasheri et al. / Virology 410 (2011) 336–344incubated at 37 °C for 4 h. In order to degrade the template DNA, 1 μL
of DNase Iwas added and the reaction was incubated for an additional
15 min at 37 °C. The in vitro transcripts were then cleaned up
using the MEGAclear™ kit (Ambion, Austin, TX) according to the
manufacturer's protocol. The concentration was determined by
measurement of the absorbance at 260 nm with an ND-1000
spectrophotometer (NanoDrop Technologies, Rockland, DE), and
RNA integrity was veriﬁed by electrophoresis on 0.8% agarose gel in
TBE.VRB assay
For the VRB assay, HCV subgenomic replicon RNA transcripts were
biotinylated at the 3'-end using the 3'-EndTag Nucleic Acid Labeling
system (Vector Laboratories, Burlingame, CA) according to the
manufacturer's protocol. The EZ-Link Maleimide-PEG11-Biotin label
(Thermo Fisher Scientiﬁc, Ottawa, ON, 20 mM) was dissolved in
RNase-free DMSO (Sigma-Aldrich, Saint Louis, MO) and the ﬁnal
reaction volume was 20 μL. Labeled HCV subgenomic replicon RNA
was then puriﬁed using the MEGAclear kit (Ambion, Austin, TX) and
the RNA integrity was veriﬁed by agarose gel electrophoresis and
quantiﬁed by measurement of the absorbance at 260 nm with an ND-
1000 spectrophotometer (NanoDrop Technologies, Rockland, DE).
In vitro hybridization of miRNAs to HCV subgenomic replicon RNA
and microbead preparation and immobilization of RNA complexes for
the assay were performed as previously described (Sagan et al., 2010).
The quantiﬁcation of signal intensities from the VRBs was
performed using Image-Pro® Plus 4.5 software (Media Cybernetics,Inc, Silver Spring, MD) by calculating the integrated optical density
(IOD) from individual beads. Net signal intensities were obtained by
local-ring background subtraction (net=raw−background). The net
signal intensity for each bead was then normalized to the area of the
bead (net IOD/area) and averaged for approximately 100 beads per
image. For normalization purposes, the net IODs from the control
hybridization reactions carried out in the absence of HCV subgenomic
replicon RNA were subtracted from the net IODs.RNA isolation and quantitative RT-PCR
For quantitative RT-PCR (q RT-PCR) analyses total RNA was isolated
from HCV subgenomic replicon-transfected Huh-7.5 cells at 72 and
120 h post-transfection using the RNeasy extraction kit (Qiagen,
Mississauga, ON). RNAextractswere then subjected toDNase I (Ambion,
Austin, TX) digestion. Total RNAwas then puriﬁedwith the DNA-free kit
(Ambion, Austin, TX). The concentration was determined by measure-
ment of the absorbance at 260 nmwith anND-1000 spectrophotometer
(NanoDrop Technologies, Rockland, DE). Approximately 0.5 μg/well of
total RNAwas loaded onto a 0.8% agarose gel to determine the integrity.
One microgram of total RNA was used for cDNA synthesis using the
Superscript II kit (Invitrogen, Burlington, ON) according to the
manufacturer's protocol. Quantitative PCR (qPCR) was performed on
an iCycler (Bio-Rad, Hercules, CA) using iQ SYBR Green Supermix (Bio-
Rad, Hercules, CA), and primers directed against the HCV IRES region
(Forward 5′-GTC TGCGGAACCGGTGAG TA-3′ andReverse 5′-GCC CAA
ATC TCC AGG CAT T-3′), and the 18 S rRNA (Forward 5′-GCG ATG CGG
CGG CGT TAT TC-3′ and Reverse 5′-CAA TCT GTC AAT CCT GTC CGT GTC
343N. Nasheri et al. / Virology 410 (2011) 336–344C-3′). A 20 μL reaction was assembled according to the manufacturer's
protocol. For data analysis, the 2−ΔΔCt method was used (Livak and
Schmittgen, 2001) and mean fold changes relative to unmutated HCV
subgenomic replicon-transfected cells were calculated. Each qPCR
experiment was carried out in triplicates and repeated three times.
Luciferase assay
Cells transfectedwithunmutatedorMRE-mutatedHCVRNA replicon
were harvested 24 or 72 h post-infection and the luciferase activity was
determined by using the luciferase reporter assay (Promega, Madison,
WI). Luciferase signal was normalized by protein content, which was
measured by Bio-Rad DC protein assay (Bio-Rad, Hercules, CA).
Northern blot analyses
Approximately 2 μg/well of total RNA was loaded onto a 1% agarose
gel. Biotinylated negative-sense probes complementary to the HCV
genome NS5B region nts 6648-7770 (Genbank accession #AJ242654)
and the β-actin gene (Genbank accession #X00351) were synthesized
using the MEGAscript™ T7 kit (Ambion, Austin, TX). In vitro transcrip-
tions were performed as described above with the inclusion of biotin-
11-UTP and biotin-11-CTP (Perkin Elmer, Boston, MA) at molar ratio of
1:3 with unlabeled UTP and unlabeled CTP, respectively. The biotiny-
lated negative-sense probeswereused at aﬁnal concentration of 2.2 ng/
uL and 0.133 ng/uL for the HCV and β-actin probes, respectively.
Northern blotting and hybridization were carried out using the
NorthernMAX kit (Ambion, Austin, TX) and Hybond XL nylon
membranes (GE Healthcare, Piscataway, NJ). The bound riboprobes
were detected using the Chemiluminescent Nucleic Acid Detection
Module (Pierce, Rockford, IL) according to the manufacturer's protocol.
Data analysis
MicroRNA-122 concentration-response data were analyzed using
the linear curve-ﬁtting program in Excel (Microsoft). Data were
presented as mean±s.d. for the indicated number of experiments.
Where indicated, statistical signiﬁcancewas assessed using two-tailed
unpaired Student's t-test.
Alignment of HCV sequences
MicroRNA-122 seed match conservation for MRE 4 was performed
using the Quickalign tool provided by the Los Alamos HCV database
(http://hcv.lanl.gov/cgi-bin/QUICK_ALIGN/QuickAlign.cgi).(Kuiken
et al., 2006). The location of MRE 4 was found in the H77 reference
sequence and used for alignment against the 465 HCV sequences in
the database. Sequences were assigned to a speciﬁc genotype and
subtype and only those classiﬁed are shown in Table S2.
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